Educational report • Compassionate, science-grounded

The Eczema Report: What’s Fact, What’s Fiction, and What You Can Do About It

Eczema and similar skin conditions can be difficult to live with. While no one knows exactly what causes eczema, research has uncovered meaningful clues—especially around barrier function, hydration, and the role of amino acids in healthy skin.

Focus: Skin barrier • hydration • comfort Key clue: Amino acids L-Serine Includes: PubMed/PMC references + US Patent 10,052,297 B2

A condition that affects more than skin

Eczema can be physically uncomfortable, emotionally exhausting, and deeply frustrating.

For many people, it’s not just about appearance. It’s about persistent itching or burning, skin that never feels comfortable, interrupted sleep, and trying countless products with only temporary results.

Despite years of research, no single cause of eczema is universally agreed upon. Genetics, immune response, environment, stress, and barrier dysfunction have all been implicated—yet none fully explain why eczema persists or why it varies so much from person to person.

Not certainty — but important clues

What is becoming clearer is that eczema may not be caused by a single trigger at all. Instead, it may develop when the skin’s natural systems fall out of balance.

Science has not delivered a single answer to eczema. But it has uncovered meaningful clues.

Eczema-prone skin may struggle to hold onto moisture.
It may have difficulty maintaining a strong protective barrier.
It may recover more slowly from everyday stressors.
It may have trouble completing normal repair cycles.

When these functions are compromised, skin can become dry, reactive, and easily irritated—even in the absence of obvious triggers.

Why conventional approaches often fall short

Many conventional approaches focus on reducing symptoms, especially itching and inflammation. For some people this can provide welcome relief, but for others symptoms return as soon as treatment stops.

Question worth asking: What if eczema persists not only because skin is irritated—but because it lacks what it needs to function normally?

Skin is a living, protein-based organ

Healthy skin is not passive. It is a living, self-renewing organ built largely from proteins.

To create and maintain these proteins, skin relies on amino acids—the same fundamental building blocks used throughout the body.

When skin is unable to access or maintain these building blocks efficiently, its ability to protect and repair itself may suffer.

Amino acids and the skin’s natural moisture system (NMF)

One of the skin’s most important hydration systems is known as Natural Moisturizing Factors (NMF). NMF are small, water-binding components inside the outermost layers of skin that help retain moisture, prevent cracking, and maintain comfort and flexibility.

Amino acids make up a significant portion of these natural moisturizing factors. When amino acid levels are reduced, skin may struggle to hold water—even when moisturizers are applied regularly.

PubMed/PMC: Barrier function, NMF, and topical amino acids Cited

Dermatology literature increasingly emphasizes that skin barrier dysfunction is central to atopic dermatitis and eczema-prone skin PubMed: 36805053.

A key clue linking barrier function to amino acids is the relationship between filaggrin breakdown and NMF. Multiple papers describe how filaggrin proteolysis produces hygroscopic components—including amino acids and related molecules—supporting hydration and barrier homeostasis PubMed: 19386895 PMC available.

In atopic dermatitis, studies have examined how filaggrin-related breakdown products (often used as NMF proxies) are reduced and how those reductions relate to disease severity PubMed: 21261659 PMC available.

Importantly, there is published research supporting the plausibility of topically delivering certain amino acids. A controlled study evaluating liposomal serine reported improved skin moisturization versus control formulations PubMed: 26557021 PMC available.

In parallel, researchers have explored “replacement NMF” concepts—hygroscopic amino-acid–based systems intended to support moisturization biology and barrier recovery PubMed: 27380298 PMC available.

In simple terms: when NMF is diminished, skin’s internal water-binding system can be compromised—helping explain the “dry, tight, flaky” feel that often persists even with frequent moisturizing.

These findings do not mean amino acids are a cure for eczema. They support a more modest conclusion: barrier and hydration biology may be influenced by the availability of NMF-related components, and topical amino-acid strategies may be a gentle direction some individuals explore alongside medical guidance.

Why L-Serine receives special attention

Among many amino acids found in healthy skin, L-Serine stands out.

L-Serine is discussed in published moisturization research as a topical delivery candidate (e.g., liposomal serine studies).
It aligns with the NMF story: supporting water-binding and comfort in the outermost skin layers.
In eczema-prone skin, barrier vulnerability and reduced NMF-related components can be consistent with a “missing materials” viewpoint.

In addition to clinical literature, US Patent 10,052,297 B2 highlights L-Serine in topical compositions intended to improve hydration and barrier-related measures.

The key idea is not that L-Serine is a drug. It is that L-Serine is a naturally occurring part of healthy skin biology, and topical delivery has been explored as a moisturization strategy.

Supply, not suppression

Many approaches attempt to suppress symptoms—calm inflammation, quiet reactivity, reduce redness. These can be helpful for symptom control, but they may not address underlying barrier vulnerability.

Emerging perspective: Skin cannot repair itself properly if it lacks the raw materials required to do so.

Amino acids—and L-Serine in particular—represent supply, not suppression. They do not force skin to behave differently; they may help provide what healthy skin already uses to maintain hydration, structure, and comfort.

What this means for people with eczema

Living with eczema can feel like an endless cycle of flare-ups and temporary relief. For many, that cycle is exhausting and discouraging.

The research summarized in this report suggests a reframing that some people may find empowering:

Eczema may persist not only because skin is reactive, but because skin may be struggling to rebuild and stabilize its barrier.
Chronic dryness may reflect a reduced or disrupted internal water-binding system tied to NMF and filaggrin-related pathways.
For some individuals, gentle strategies that support moisturization biology—including NMF-linked approaches and topical amino-acid concepts—may be worth exploring as part of a broader barrier-support plan.

This perspective does not replace medical care. It does not promise results. And it does not suggest one solution fits everyone. It simply highlights a possible path: focusing on barrier support and restoration, rather than symptom suppression alone.

Sometimes relief begins not with stronger intervention—but with better understanding and more supportive inputs.

If symptoms are severe, persistent, or worsening—or if you suspect infection—consult a qualified healthcare professional.

Selected references (PubMed/PMC + Patent) Complete

Provided for transparency and educational context.

Robinson M, Visscher M, Laruffa A, Wickett R. Natural moisturizing factors (NMF) in the stratum corneum (SC). I. Effects of lipid extraction and soaking. J Cosmet Sci. 2010. PMID: 20211113. PubMed
Sandilands A, Sutherland C, Irvine AD, McLean WHI. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009. PMID: 19386895. PubMed • PMC
Moosbrugger-Martinz V, et al. Revisiting the Roles of Filaggrin in Atopic Dermatitis. Int J Mol Sci. 2022. PMID: 35628125. PubMed • PMC
Purnamawati S, et al. The Role of Moisturizers in Addressing Various Kinds of Dermatitis. Clin Med Res. 2017. PMID: 29229630. PubMed • PMC
Del Rosso JQ, Zeichner J, Alexis A, et al. Understanding the Epidermal Barrier in Healthy and Compromised Skin: Clinically Relevant Information for the Dermatology Practitioner. J Clin Aesthet Dermatol. 2016. PMID: 28936279. PubMed • PMC
Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004. PMID: 14728698. PubMed
Verdier-Sévrain S, Bonté F. Skin hydration: a review on its molecular mechanisms. J Cosmet Dermatol. 2007. PMID: 17524122. PubMed
Kezic S, et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. (2011). PMID: 21261659. PubMed • PMC
Kim H, et al. Combined Skin Moisturization of Liposomal Serine Incorporated in Hydrogels… (2015). PMID: 26557021. PubMed • PMC
Arezki NR, et al. Design, synthesis and characterization of linear unnatural amino acids for skin moisturisation (replacement NMF concept). (2016/2017). PMID: 27380298. PubMed • PMC
Baldwin H. Going Beyond Ceramides in Moisturizers: The Role of Natural Moisturizing Factors. J Drugs Dermatol. 2024. PMID: 38834224. PubMed
US Patent 10,052,297 B2. Topical compositions comprising amino acids for improving skin hydration and barrier function.

References are provided for educational support. This report is not a substitute for professional medical advice.

The Eczema Report

The Eczema Report: What’s Fact, What’s Fiction, and What You Can Do About It